We are live on ! Find out more
MAM

Melqart Asset Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 84.85%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+84.85%
3 Year Est. Return
+183.09%
5 Year Est. Return
+319.83%
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
+$92.5M
Cap. Flow
-$8.37M
Cap. Flow %
-0.7%
Top 10 Hldgs %
60.53%
Holding
49
New
22
Increased
3
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$60.6M
2
TIF
Tiffany & Co.
TIF
+$41.5M
3
INXN
Interxion Holding N.V.
INXN
+$40.1M
4
WMGI
Wright Medical Group Inc
WMGI
+$35.8M
5
HGV icon
Hilton Grand Vacations
HGV
+$32.8M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$144M
2
ALDR
Alder Biopharmaceuticals
ALDR
+$50.5M
3
VSM
Versum Materials, Inc.
VSM
+$47.1M
4
NLSN
Nielsen Holdings plc
NLSN
+$36.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$33.1M

Sector Composition

Rank Sector Weight
1 Technology 33.9%
2 Healthcare 25.73%
3 Communication Services 8.97%
4 Consumer Discretionary 7.1%
5 Industrials 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$135M 11.28%
704,000
+95,300
+16% +$17.2M
NXPI icon
2
NXP Semiconductors
NXPI
$68B
$97.3M 8.16%
764,935
-285,065
-27% -$33.1M
CY
3
DELISTED
Cypress Semiconductor
CY
$79.6M 6.67%
3,413,000
-410,000
-11% -$9.59M
ZAYO
4
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$76.3M 6.39%
2,201,000
– –
PPLI
5
People Inc
PPLI
$3.1B
$66.9M 5.6%
+1,502,154
New +$60.6M
MLNX
6
DELISTED
Mellanox Technologies, Ltd.
MLNX
$64.1M 5.37%
547,088
-81,303
-13% -$9.24M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$121B
$63M 5.28%
287,900
+127,900
+80% +$25.9M
WBC
8
DELISTED
WABCO HOLDINGS INC.
WBC
$51.9M 4.35%
383,000
– –
TIF
9
DELISTED
Tiffany & Co.
TIF
$47M 3.94%
+351,500
New +$41.5M
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
$41.7M 3.5%
+1,369,000
New +$35.8M
AVYA
11
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$41.2M 3.45%
3,050,000
-462,988
-13% -$5.68M
INXN
12
DELISTED
Interxion Holding N.V.
INXN
$40.2M 3.37%
+480,000
New +$40.1M
LOGM
13
DELISTED
LogMein, Inc.
LOGM
$34.9M 2.92%
+406,750
New +$30.2M
HGV icon
14
Hilton Grand Vacations
HGV
$3.84B
$32.8M 2.75%
+954,200
New +$32.8M
MDCO
15
CALL
DELISTED
Medicines Co
MDCO
$31.8M 2.66%
+374,200
New +$25M
TAK icon
16
Takeda Pharmaceutical
TAK
$55.1B
$30.7M 2.57%
1,557,000
-115,350
-7% -$2.21M
TECD
17
DELISTED
Tech Data Corp
TECD
$26.6M 2.23%
+185,000
New +$23.8M
INST
18
DELISTED
Instructure, Inc.
INST
$20.8M 1.74%
+431,660
New +$20.2M
QIWI
19
DELISTED
QIWI PLC
QIWI
$20.6M 1.73%
1,066,026
+42,387
+4% +$828K
MDCO
20
DELISTED
Medicines Co
MDCO
$20.3M 1.7%
+239,000
New +$15.9M
CISN
21
DELISTED
Cision Ltd. Ordinary Share
CISN
$19.7M 1.65%
+1,975,000
New +$18.9M
ASND icon
22
Ascendis Pharma A/S
ASND
$16.7B
$16.1M 1.35%
+115,404
New +$12.8M
BOLD
23
PUT
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.8M 1.15%
+230,000
New +$8.63M
RNG icon
24
RingCentral
RNG
$4.05B
$12.6M 1.05%
74,413
-28,821
-28% -$4.75M
QGEN icon
25
Qiagen
QGEN
$8.53B
$12.5M 1.05%
+349,496
New +$13M
1
2

Similar funds

LPAM
Lodestar Private Asset Management Alamo, California $1.01B AUM 16.61% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
COI
Connable Office Inc Kalamazoo, Michigan $1.02B AUM 19.74% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
MCM
MV Capital Management Bethesda, Maryland $1.02B AUM 14.02% 1-Year Est. Return

Melqart Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Melqart Asset Management held 49 positions worth $1.19B, up 8.4% from $1.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Melqart Asset Management's Q4 2019 filing shows 22 new, 3 increased, 10 reduced and 9 closed positions. Its largest new stake was People Inc: 1,502,154 shares worth $66.9M. The largest sale was Celgene Corp, an estimated $144M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Communication Services.

  • Melqart Asset Management's largest Q4 2019 buy was People Inc: 1,502,154 shares worth $66.9M.
  • Melqart Asset Management added most to Vertex Pharmaceuticals in Q4 2019, an estimated $25.9M increase.
  • Melqart Asset Management's biggest Q4 2019 reduction was NXP Semiconductors, cutting an estimated $33.1M.
  • Melqart Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $144M.
  • Melqart Asset Management's ten largest holdings make up 61% of its $1.19B portfolio in Q4 2019.
  • Melqart Asset Management opened 22 new positions and closed 9 in Q4 2019.
  • Melqart Asset Management's portfolio value rose 8.4% quarter-over-quarter to $1.19B.

Based on Melqart Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.